Repositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesions

Algire, 2011, Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo, Oncogene, 30, 1174, 10.1038/onc.2010.483

Algire, 2010, Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase, Endocr. Relat. Cancer, 17, 351, 10.1677/ERC-09-0252

Alimova, 2009, Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro, Cell Cycle, 8, 909, 10.4161/cc.8.6.7933

Alli, 2005, Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice, Oncogene, 24, 39, 10.1038/sj.onc.1208174

Anisimov, 2010, Metformin for aging and cancer prevention, Aging (Albany, NY), 2, 760, 10.18632/aging.100230

Ansieau, 2010, TWISTing an embryonic transcription factor into an oncoprotein, Oncogene, 29, 3173, 10.1038/onc.2010.92

Arima, 2008, Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition, Cancer Res., 68, 5104, 10.1158/0008-5472.CAN-07-5680

Armengol, 2007, 4E-binding protein 1: a key molecular “funnel factor” in human cancer with clinical implications, Cancer Res., 67, 7551, 10.1158/0008-5472.CAN-07-0881

Arnal-Estape, 2010, HER2 silences tumor suppression in breast cancer cells by switching expression of C/EBPss isoforms, Cancer Res., 70, 9927, 10.1158/0008-5472.CAN-10-0869

Batsche, 1998, RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2, Mol. Cell. Biol., 18, 3647, 10.1128/MCB.18.7.3647

Ben Sahra, 2010, Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells, Cancer Res., 70, 2465, 10.1158/0008-5472.CAN-09-2782

Ben Sahra, 2008, The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level, Oncogene, 27, 3576, 10.1038/sj.onc.1211024

Ben Sahra, 2010, Metformin in cancer therapy: a new perspective for an old antidiabetic drug?, Mol. Cancer Ther., 9, 1092, 10.1158/1535-7163.MCT-09-1186

Ben Sahra, 2010, The combination of metformin and 2-deoxyglucose inhibits autophagy and induces AMPK dependent apoptosis in prostate cancer cells, Autophagy, 6, 670, 10.4161/auto.6.5.12434

Bendall, 2007, IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro, Nature, 448, 1015, 10.1038/nature06027

Berstein, 2010, Modern approach to metabolic rehabilitation of cancer patients: biguanides (phenformin and metformin) and beyond, Future Oncol., 6, 1313, 10.2217/fon.10.87

Bodmer, 2010, Long-term metformin use is associated with decreased risk of breast cancer, Diabetes Care, 33, 1304, 10.2337/dc09-1791

Bosco, 2007, RB in breast cancer: at the crossroads of tumorigenesis and treatment, Cell Cycle, 6, 667, 10.4161/cc.6.6.3988

Boya, 2005, Inhibition of macroautophagy triggers apoptosis, Mol. Cell. Biol., 25, 1025, 10.1128/MCB.25.3.1025-1040.2005

Boyerinas, 2010, The role of let-7 in cell differentiation and cancer, Endocr. Relat. Cancer, 17, F19, 10.1677/ERC-09-0184

Brabletz, 2010, The ZEB/miR-200 feedback loop—a motor of cellular plasticity in development and cancer?, EMBO Rep., 11, 670, 10.1038/embor.2010.117

Braig, 2006, Oncogene-induced senescence: putting the brakes on tumor development, Cancer Res., 66, 2881, 10.1158/0008-5472.CAN-05-4006

Brunet, 2008, BRCA1 and acetyl-CoA carboxylase: the metabolic syndrome of breast cancer, Mol. Carcinog., 47, 157, 10.1002/mc.20364

Burkhart, 2008, Cellular mechanisms of tumour suppression by the retinoblastoma gene, Nat. Rev. Cancer, 8, 671, 10.1038/nrc2399

Buzzai, 2007, Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth, Cancer Res., 67, 6745, 10.1158/0008-5472.CAN-06-4447

Campaner, 2010, Cdk2 suppresses cellular senescence induced by the c-myc oncogene, Nat. Cell Biol., 12, 54, 10.1038/ncb2004

Chen, 2010, Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion, Br. J. Cancer, 102, 351, 10.1038/sj.bjc.6605486

Collado, 2010, Senescence in tumours: evidence from mice and humans, Nat. Rev. Cancer, 10, 51, 10.1038/nrc2772

Creighton, 2010, Epithelial–mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer, J. Mammary Gland Biol. Neoplasia, 15, 253, 10.1007/s10911-010-9173-1

Dontu, 2003, In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells, Genes Dev., 17, 1253, 10.1101/gad.1061803

Dowling, 2007, Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells, Cancer Res., 67, 10804, 10.1158/0008-5472.CAN-07-2310

Eberle, 2004, SREBP transcription factors: master regulators of lipid homeostasis, Biochimie, 86, 839, 10.1016/j.biochi.2004.09.018

Elmore, 2002, Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction, J. Biol. Chem., 277, 35509, 10.1074/jbc.M205477200

Espina, 2011, What is the malignant nature of human ductal carcinoma in situ?, Nat. Rev. Cancer, 11, 68, 10.1038/nrc2950

Espina, 2010, Malignant precursor cells pre-exist in human breast DCIS and require autophagy for survival, PLoS One, 5, e10240, 10.1371/journal.pone.0010240

Esslimani-Sahla, 2007, Increased expression of fatty acid synthase and progesterone receptor in early steps of human mammary carcinogenesis, Int. J. Cancer, 120, 224, 10.1002/ijc.22202

Fillmore, 2010, Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling, Proc. Natl. Acad. Sci. U.S.A., 107, 21737, 10.1073/pnas.1007863107

Gatenby, 2008, A microenvironmental model of carcinogenesis, Nat. Rev. Cancer, 8, 56, 10.1038/nrc2255

Gauthier, 2007, Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors, Cancer Cell, 12, 479, 10.1016/j.ccr.2007.10.017

Giovannucci, 2010, Diabetes and cancer: a consensus report, CA Cancer J. Clin., 60, 207, 10.3322/caac.20078

Gonzalez-Angulo, 2010, Metformin: a therapeutic opportunity in breast cancer, Clin. Cancer Res., 16, 1695, 10.1158/1078-0432.CCR-09-1805

Goodwin, 2008, Insulin-lowering effects of metformin in women with early breast cancer, Clin. Breast Cancer, 8, 501, 10.3816/CBC.2008.n.060

Goodwin, 2011, Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents, Breast Cancer Res. Treatm., 126, 215, 10.1007/s10549-010-1224-1

Hannemann, 2006, Classification of ductal carcinoma in situ by gene expression profiling, Breast Cancer Res., 8, R61, 10.1186/bcr1613

Hirsch, 2009, Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission, Cancer Res., 69, 7507, 10.1158/0008-5472.CAN-09-2994

Hochachka, 1980

Hochachka, 2002, Going malignant: the hypoxia-cancer connection in the prostate, Bioessays, 24, 749, 10.1002/bies.10131

Horwitz, 2008, Progestins in hormone replacement therapies reactivate cancer stem cells in women with preexisting breast cancers: a hypothesis, J. Clin. Endocrinol. Metab., 93, 3295, 10.1210/jc.2008-0938

Hosono, 2010, Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial, Cancer Prev. Res. (Phila), 3, 1077, 10.1158/1940-6207.CAPR-10-0186

Hugo, 2011, Defining the E-cadherin repressor interactome in epithelial–mesenchymal transition: the PMC42 model as a case study, Cells Tissues Organs, 193, 23, 10.1159/000320174

Ibarra, 2007, A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells, Genes Dev., 21, 3238, 10.1101/gad.1616307

Janda, 2006, Raf plus TGFbeta-dependent EMT is initiated by endocytosis and lysosomal degradation of E-cadherin, Oncogene, 25, 7117, 10.1038/sj.onc.1209701

Jiang, 2010, The RB-E2F1 pathway regulates autophagy, Cancer Res., 70, 7882, 10.1158/0008-5472.CAN-10-1604

Jiang, 2010, Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status, J. Clin. Invest., 120, 3296, 10.1172/JCI41490

Jiralerspong, 2009, Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer, J. Clin. Oncol., 27, 3297, 10.1200/JCO.2009.19.6410

Jonasson, 2009, Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden, Diabetologia, 52, 1745, 10.1007/s00125-009-1444-2

Karantza-Wadsworth, 2007, Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis, Genes Dev., 21, 1621, 10.1101/gad.1565707

Kelloff, 2007, Assessing intraepithelial neoplasia and drug safety in cancer-preventive drug development, Nat. Rev. Cancer, 7, 508, 10.1038/nrc2154

Knudsen, 2008, Tailoring to RB: tumour suppressor status and therapeutic response, Nat. Rev. Cancer, 8, 714, 10.1038/nrc2401

Kroemer, 2005, Lysosomes and autophagy in cell death control, Nat. Rev. Cancer, 5, 886, 10.1038/nrc1738

Lacerda, 2010, The role of tumor initiating cells in drug resistance of breast cancer: implications for future therapeutic approaches, Drug Resist. Updates, 13, 99, 10.1016/j.drup.2010.08.001

Lee, 2006, Senescence-associated beta-galactosidase is lysosomal beta-galactosidase, Aging Cell, 5, 187, 10.1111/j.1474-9726.2006.00199.x

Li, 2006, Normal stem cells and cancer stem cells: the niche matters, Cancer Res., 66, 4553, 10.1158/0008-5472.CAN-05-3986

Li, 2008, Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy, J. Natl. Cancer Inst., 100, 672, 10.1093/jnci/djn123

Liu, 2009, Metformin induces unique biological and molecular responses in triple negative breast cancer cells, Cell Cycle, 8, 2031, 10.4161/cc.8.13.8814

Liu, 2009, Mouse fibroblasts lacking RB1 function form spheres and undergo reprogramming to a cancer stem cell phenotype, Cell Stem Cell, 4, 336, 10.1016/j.stem.2009.02.015

Liu, 2008, Zeb1 links epithelial–mesenchymal transition and cellular senescence, Development (Cambridge, England), 135, 579, 10.1242/dev.007047

Louie, 2010, Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation, Breast Cancer Res., 12, R94, 10.1186/bcr2773

Lu, 2005, Fatty acid synthase is a potential molecular target for the chemoprevention of breast cancer, Carcinogenesis, 26, 153, 10.1093/carcin/bgh278

Lum, 2005, Autophagy in metazoans: cell survival in the land of plenty, Nat. Rev. Mol. Cell Biol., 6, 439, 10.1038/nrm1660

Lundgren, 2009, Hypoxia, Snail and incomplete epithelial–mesenchymal transition in breast cancer, Br. J. Cancer, 101, 1769, 10.1038/sj.bjc.6605369

Magnifico, 2009, Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab, Clin. Cancer Res., 15, 2010, 10.1158/1078-0432.CCR-08-1327

Martin, 2010, Tumorigenesis: Twist1 links EMT to self-renewal, Nat. Cell Biol., 12, 924, 10.1038/ncb1010-924

Martin-Castillo, 2010, Incorporating the antidiabetic drug metformin in HER2-positive breast cancer treated with neo-adjuvant chemotherapy and trastuzumab: an ongoing clinical-translational research experience at the Catalan Institute of Oncology, Ann. Oncol., 21, 187, 10.1093/annonc/mdp494

Martin-Castillo, 2010, Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena, Cell Cycle, 9, 1057, 10.4161/cc.9.6.10994

Mathew, 2007, Role of autophagy in cancer, Nat. Rev. Cancer, 7, 961, 10.1038/nrc2254

Meley, 2006, AMP-activated protein kinase and the regulation of autophagic proteolysis, J. Biol. Chem., 281, 34870, 10.1074/jbc.M605488200

Memmott, 2009, LKB1 and mammalian target of rapamycin as predictive factors for the anticancer efficacy of metformin, J. Clin. Oncol., 27, e226, 10.1200/JCO.2009.25.3963

Menendez, 2011, Gerosuppressant metformin: less is more, Aging (Albany, NY)

Menendez, 2004, Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation, Mol. Carcinog., 41, 164, 10.1002/mc.20054

Menendez, 2009, Int. J. Oncol., 34, 43

Mineno, 2006, The expression profile of microRNAs in mouse embryos, Nucleic Acids Res., 34, 1765, 10.1093/nar/gkl096

Morel, 2008, Generation of breast cancer stem cells through epithelial–mesenchymal transition, PLoS One, 3, e2888, 10.1371/journal.pone.0002888

Morgan, 2010, More patent protection for medicines with a new purpose, Nature, 465, 1005, 10.1038/4651005b

Muggerud, 2010, Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer, Mol. Oncol., 4, 357, 10.1016/j.molonc.2010.06.007

Muthuswamy, 2001, ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini, Nat. Cell Biol., 3, 785, 10.1038/ncb0901-785

Negri, 2010, Chromosome band 17q21 in breast cancer: significant association between beclin 1 loss and HER2/NEU amplification, Genes Chromosomes Cancer, 49, 901, 10.1002/gcc.20798

Ohashi, 2010, Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors, Cancer Res., 70, 4174, 10.1158/0008-5472.CAN-09-4614

Oliveras-Ferraros, 2011, Micro(mi)RNA expression profile of breast cancer epithelial cells treated with the anti-diabetic drug metformin: Induction of the tumor suppressor miRNA let-7a and suppression of the TGFβ-induced oncomiR miRNA-181a, Cell Cycle, 10, 1144, 10.4161/cc.10.7.15210

Palacios, 2005, Lysosomal targeting of E-cadherin: a unique mechanism for the down-regulation of cell–cell adhesion during epithelial to mesenchymal transitions, Mol. Cell. Biol., 25, 389, 10.1128/MCB.25.1.389-402.2005

Park, 2007, Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2, Cell Cycle, 6, 2585, 10.4161/cc.6.21.4845

Peinado, 2008, A hypoxic twist in metastasis, Nat. Cell Biol., 10, 253, 10.1038/ncb0308-253

Peter, 2009, Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression, Cell Cycle, 8, 843, 10.4161/cc.8.6.7907

Pollak, 2008, Insulin and insulin-like growth factor signalling in neoplasia, Nat. Rev. Cancer, 8, 915, 10.1038/nrc2536

Pollak, 2010, Metformin and other biguanides in oncology: advancing the research agenda, Cancer Prev. Res. (Phila), 3, 1060, 10.1158/1940-6207.CAPR-10-0175

Pollak, 2010, Insulin analogues and cancer risk: cause for concern or cause celebre?, Int. J. Clin. Pract., 64, 628, 10.1111/j.1742-1241.2010.02354.x

Reichert, 2003, Trends in development and approval times for new therapeutics in the United States, Nat. Rev. Drug Discov., 2, 695, 10.1038/nrd1178

Rice, 2009, Metformin inhibits aromatase via an extracellular signal-regulated kinase-mediated pathway, Endocrinology, 150, 4794, 10.1210/en.2009-0540

Rodier, 2011, Four faces of cellular senescence, J. Cell Biol., 192, 546, 10.1083/jcb.201009094

Rubinsztein, 2007, Potential therapeutic applications of autophagy, Nat. Rev. Drug Discov., 6, 304, 10.1038/nrd2272

Samaddar, 2008, A role for macroautophagy in protection against 4-hydroxytamoxifen-induced cell death and the development of antiestrogen resistance, Mol. Cancer Ther., 7, 2977, 10.1158/1535-7163.MCT-08-0447

Schoenlein, 2009, Autophagy facilitates the progression of ERalpha-positive breast cancer cells to antiestrogen resistance, Autophagy, 5, 400, 10.4161/auto.5.3.7784

Serrano, 2010, Cancer: a lower bar for senescence, Nature, 464, 363, 10.1038/464363a

Shell, 2007, Let-7 expression defines two differentiation stages of cancer, Proc. Natl. Acad. Sci. U.S.A., 104, 11400, 10.1073/pnas.0704372104

Shiota, 2008, Twist and p53 reciprocally regulate target genes via direct interaction, Oncogene, 27, 5543, 10.1038/onc.2008.176

Singh, 2010, EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer, Oncogene, 29, 4741, 10.1038/onc.2010.215

Smit, 2010, Epithelial–mesenchymal transition and senescence: two cancer-related processes are crossing paths, Aging (Albany, NY), 2, 735, 10.18632/aging.100209

Stoll, 2000, Biological mechanisms in breast cancer invasiveness: relevance to preventive interventions, Eur. J. Cancer Prev., 9, 73, 10.1097/00008469-200004000-00002

Stoll, 2002, Oestrogen/insulin-like growth factor-I receptor interaction in early breast cancer: clinical implications, Ann. Oncol., 13, 191, 10.1093/annonc/mdf059

Swinnen, 2005, Mimicry of a cellular low energy status blocks tumor cell anabolism and suppresses the malignant phenotype, Cancer Res., 65, 2441, 10.1158/0008-5472.CAN-04-3025

Tracy, 2007, BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy, Mol. Cell. Biol., 27, 6229, 10.1128/MCB.02246-06

Tsai, 2011, Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWIST, Blood, 117, 459, 10.1182/blood-2010-05-287508

Vazquez-Martin, 2010, Metformin and energy metabolism in breast cancer: from insulin physiology to tumour-initiating stem cells, Curr. Mol. Med., 10, 674, 10.2174/156652410792630625

Vazquez-Martin, 2009, The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells, Cell Cycle, 8, 88, 10.4161/cc.8.1.7499

Vazquez-Martin, 2009, Autophagy facilitates the development of breast cancer resistance to the anti-HER2 monoclonal antibody trastuzumab, PLoS One, 4, e6251, 10.1371/journal.pone.0006251

Wang, 2010, Targeting miRNAs involved in cancer stem cell and EMT regulation: an emerging concept in overcoming drug resistance, Drug Resist. Updat., 13, 109, 10.1016/j.drup.2010.07.001

Weinberg, 2008, Twisted epithelial–mesenchymal transition blocks senescence, Nat. Cell Biol., 10, 1021, 10.1038/ncb0908-1021

Welch, 1997, Using autopsy series to estimate the disease “reservoir” for ductal carcinoma in situ of the breast: how much more breast cancer can we find?, Ann. Intern. Med., 127, 1023, 10.7326/0003-4819-127-11-199712010-00014

Yang, 2010, Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition, Nat. Cell Biol., 12, 982, 10.1038/ncb2099

Yang, 2008, Direct regulation of TWIST by HIF-1alpha promotes metastasis, Nat. Cell Biol., 10, 295, 10.1038/ncb1691

Yang, 2008, TWIST activation by hypoxia inducible factor-1 (HIF-1): implications in metastasis and development, Cell Cycle, 7, 2090, 10.4161/cc.7.14.6324

Zakikhani, 2006, Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells, Cancer Res., 66, 10269, 10.1158/0008-5472.CAN-06-1500

Zheng, 2004, Regulation of cellular senescence and p16(INK4a) expression by Id1 and E47 proteins in human diploid fibroblast, J. Biol. Chem., 279, 31524, 10.1074/jbc.M400365200

Zhou, 2001, Role of AMP-activated protein kinase in mechanism of metformin action, J. Clin. Invest., 108, 1167, 10.1172/JCI13505